Department of Defense (DoD).
Notice of meeting.
Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix as amended), the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in accordance with section 10(a)(2) of Public Law, a Defense Health Board (DHB) meeting is announced:
November 14, 2011
9:30 a.m.-12 p.m. (Open Session).
12 p.m.-1 p.m. (Administrative Working Meeting).
1 p.m.-5 p.m. (Open Session).
Hilton Crystal City at Washington/Reagan National Airport, 2399 Jefferson Davis Highway, Arlington, VA 22202.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ms. Christine Bader, Director, Defense Health Board, 5111 Leesburg Pike, Suite Start Printed Page 65185810, Falls Church, Virginia 22041-3206, (703) 681-8448, Ext. 1215, Fax: (703) 681-3317, Christine.firstname.lastname@example.org.End Further Info End Preamble Start Supplemental Information
Additional information, including the agenda and electronic registration are available at the DHB Web site, http://www.health.mil/dhb/default.cfm. Anyone intending to attend is encouraged to register to ensure that adequate seating is available.
Purpose of the Meeting
The purpose of the meeting is to address and deliberate pending and new issues before the Board.
On November 14, 2011, the Board will receive briefings regarding military health needs and priorities from guest speakers and representatives of the Department of Defense.
Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through 102-3.165 and subject to availability of space, the DHB meeting on November 14, 2011 will be open to the public from 9:30 a.m. to 12 p.m. and 1 p.m. to 5 p.m.
Any member of the public wishing to provide comments to the DHB may do so in accordance with 41 CFR 102-3.140(C) and section 10(a)(3) of the Federal Advisory Committee Act, and the procedures described in this notice.
Individuals desiring to provide comments to the DHB may do so by submitting a written statement to the DHB Designated Federal Officer (DFO) (see FOR FURTHER INFORMATION CONTACT). Written statements should address the following details: the issue, discussion, and a recommended course of action. Supporting documentation may also be included, as needed, to establish the appropriate historical context and to provide any necessary background information.
If the written statement is not received at least 10 calendar days prior to the meeting, the DFO may choose to postpone consideration of the statement until the next open meeting.
The DFO will review all timely submissions with the DHB President and ensure they are provided to members of the DHB before the meeting that is subject to this notice. After reviewing the written comments, the Chairperson and the DFO may choose to invite the submitter to orally present their issue during an open portion of this meeting or at a future meeting. The DFO, in consultation with the DHB Chairperson, may allot time for members of the public to present their issues for review and discussion by the Defense Health Board.
If special accommodations are required to attend (sign language, wheelchair accessibility) please contact Ms. Lisa Jarrett at (703) 681-8448 ext. 1280 by November 1, 2011.Start Signature
Dated: October 17, 2011.
Alternate OSD Federal Register Liaison, Department of Defense.
[FR Doc. 2011-27202 Filed 10-19-11; 8:45 am]
BILLING CODE 5001-06-P